ESR(01821.HK):兩董事向主要股東OMERS購3,059萬股股份
ESR(01821.HK)公布,Redwood Investment於今年12月15日訂立買賣協議,以向公司主要股東OMERS Administration 收購3,058.71萬股公司股份,佔公司已發行股本約1%。買方分別由執行董事、聯合創始人兼集團聯席首席執行官Stuart Gibson以及執行董事、聯合創始人兼集團總裁Charles Alexander Portes間接擁有50%及50%。預期收購事項將於2020年12月23日完成。
收購事項完成後,Stuart Gibson及Charles Alexander Portes持股將增至14.79%及14.79%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.